Advertisement

Richard Payerchin

Richard Payerchin is an editor of Medical Economics, a sister brand to Infection Control Today.

Articles

ACIP Updates Recommendation for Universal Infant Hepatitis B Vaccination

December 06, 2025

The Advisory Committee on Immunization Practices (ACIP) has revised its long-standing recommendation for universal infant hepatitis B vaccination, shifting to an individualized, parent–provider decision-making model for babies born to hepatitis B–negative mothers. The change sparked intense debate among committee members.

New ACIP Panel Backs Seasonal Flu, RSV Vaccinations, but Divisions Emerge Over Thimerosal and Infant Dosing

June 27, 2025

In its first major session under newly appointed leadership, the revamped Advisory Committee on Immunization Practices (ACIP) voted to support flu and RSV vaccinations for the 2025–2026 season, but internal debate over vaccine preservatives, access equity, and risk assessment highlighted the ideological and scientific tensions now shaping federal vaccine policy.

A Controversial Reboot: New Vaccine Panel Faces Scrutiny, Support, and Sharp Divides

June 26, 2025

As the newly appointed Advisory Committee on Immunization Practices (ACIP) met for the first time under sweeping changes by HHS Secretary Robert F. Kennedy Jr, the national spotlight turned to the panel’s legitimacy, vaccine guidance, and whether science or ideology would steer public health policy in a polarized era.

Advertisement
Advertisement